Form 8-K - Current report:
SEC Accession No. 0000882095-21-000010
Filing Date
2021-04-29
Accepted
2021-04-29 16:06:01
Documents
16
Period of Report
2021-04-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gild-20210429.htm   iXBRL 8-K 41115
2 EXHIBIT 99.1 exhibit991earningspressrel.htm EX-99.1 462883
8 GRAPHIC gcp_primarylarge1a.jpg GRAPHIC 824580
  Complete submission text file 0000882095-21-000010.txt   1792004

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gild-20210429.xsd EX-101.SCH 2433
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gild-20210429_cal.xml EX-101.CAL 721
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gild-20210429_def.xml EX-101.DEF 1659
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gild-20210429_lab.xml EX-101.LAB 24275
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gild-20210429_pre.xml EX-101.PRE 12657
9 EXTRACTED XBRL INSTANCE DOCUMENT gild-20210429_htm.xml XML 11081
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES INC (Filer) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19731 | Film No.: 21870481
SIC: 2836 Biological Products, (No Diagnostic Substances)